The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) is seeking applications for the 2026 Advancing Oncologic Research Communities in Health Equity (ARCH) K12 Program. This will be the first cohort of Scholars from UMB.

The purpose of this program is to enhance research training and education of post-doctoral fellows, junior faculty, and other early-stage investigators in implementing oncology research that considers population-level factors influencing health outcomes. This award supports career development awards designed to prepare newly trained clinicians who are committed to independent research careers in community oncology, prevention, or treatment research, and to facilitate their transition to more advanced support mechanisms or independent research funding (e.g., K08 or R01-equivalent). 

This request for applications is for new Scholars from UMB, including post-doctoral fellows, junior faculty, and other early-stage investigators.  Support, including salary, research funds, tuition fees, and travel funds are provided for two years. 

Fundamental elements of the award include: structured, foundational coursework; didactic and hands-on training in clinical and translational research through a formal program of instruction; training in manuscript preparation and grant submission; participation in career development opportunities; and designated mentors that will support the Scholar throughout the period of K12 award and on an ongoing basis thereafter until the Scholar achieves promotion with tenure. 

Funding for these awards is provided by the National Cancer Institute of the National Institutes of Health under The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (Award Number K12CA301384).  

If you have questions about this RFA or online application process, please email ARCHK12@som.umaryland.edu.